Related Experiment Video
Updated: Jul 25, 2025
Surgical Treatment for Benign Prostatic Hyperplasia: Holmium Laser Enucleation of the Prostate HoLEP.
Published on: March 6, 2018
Holmium laser enucleation of the prostate (HoLEP) as same-day surgery: A safe and feasible option
R Blanco Fernández1, I González Rodríguez1, S Fernández-Pello Montes1
1Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
Objective:
To study the feasibility of holmium laser enucleation (HoLEP) performed as a same-day surgery.
Material And Methods:
Prospective observational study including 25 patients submitted to HoLEP. Patients were discharged the same day if they met the established criteria.
Results:
The mean age of the patients was 65.1 years and prostate volume was 45.8cc. All patients were discharged the same day of surgery. The overall complication rate at 30 days was 12% (Clavien I 100%). The rate of re-hospitalization was 0%. Patient satisfaction rate with the day surgery pathway was 95%.
Conclusions:
The initial analysis of our results suggests that outpatient HoLEP is a safe and effective alternative with low rate of complications. According to satisfaction rates, patients prefer the day surgery pathway for the performance of HoLEP.
